Oaxaca de Juarez.- The National Council of Science and Technology (Conacit) reported to keep open the registry to recruit volunteers to comply with the final stage of clinical development of HomelandMexican vaccine against COVID-19.
He pointed out that he is looking for people who live in six specific cities in the country, including Oaxaca de Juarez; Also search in Mexico City, Morelia (Michoacán), Mérida (Yucatán), Tlalnepantla (State of Mexico) and Acapulco (Guerrero).
This final stage requires at least 3 thousand 860 volunteers and volunteerswhich takes place under a protocol approved by the National Committee for Science, Technology and Innovation in Public Health (CNCTI-SP) and the Federal Commission for Protection from Health Risks (Cofepris).
“Importantly, preliminary results from the clinical development phases to date show that Patria® is safe, promotes antibody generation, and has the potential to be used as a universal booster,” Conacyt, which works in the vaccine in collaboration with the Avi-Mex laboratory.
Once volunteers have completed the registration form in patria.conacyt.mx, your data will be processed and sent to the Clinical Research Center selected by the volunteer and person authorized to carry out the evaluation. Once the review period has passed, a person representing Recruitment will contact you to set up a face-to-face appointment.
“All individuals advancing to this recruitment phase will be thoroughly briefed on the full clinical trial protocol, follow-up and monitoring dates, as well as any other questions about the trial. Specialists will accompany the volunteers throughout the process of solving problems, before signing a letter of informed consent.
The personal and medical information provided by the volunteers will be absolutely confidential; It will not be shared with third parties and will be protected by data protection law.
Volunteers must have 18 years or olderhave at least one dose of the Covid-19 vaccine and have waited four months since the last vaccine or booster application.
Pregnant or nursing people cannot participate in this call. All volunteers must be in good general health; If any chronic disease is present, it should be monitored for at least three months prior to the start of the study.
